Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Anus Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Papillomavirus Infections 2Neuroblastoma 2Liver Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2HIV Infections 2Gallbladder Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Bile Duct Neoplasms 2Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Smoldering Multiple Myeloma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Precancerous Conditions 1Pleuropulmonary blastoma 1Pancreatic Neuroendocrine Tumors (pNET) 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neurofibrosarcoma 1

Interventions

dinutuximab 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Cyclophosphamide 3Carboplatin 3Biopsy 3Vincristine 2Topotecan 2Thiotepa 2Temozolomide 2Stem Cell Transplantation 2Specimen Handling 2Radiation 2Platinum 2Melphalan 2Isotretinoin 2Irinotecan 2Etoposide 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2sargramostim 1lorlatinib 1etoposide phosphate 1Watchful Waiting 1Transurethral Resection of Bladder 1Razoxane 1Radiotherapy 1Observation 1Nuclear Medicine Department, Hospital 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ganglioneuroblastoma × Watchful Waiting × Clear all
NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Children's Oncology Group

Phase 3 Active not recruiting
621 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡